טוען...
S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature
Hepatocellular carcinoma (HCC) is the most common liver neoplasm worldwide. Based on its potent inhibition of dihydropyrimidine dehydrogenase (DPD), S-1 is expected to be more active than other fluoropyrimidines against HCC with DPD activity. This systematic review was aimed to assess the efficacy a...
שמור ב:
| הוצא לאור ב: | Contemp Oncol (Pozn) |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Termedia Publishing House
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5385475/ https://ncbi.nlm.nih.gov/pubmed/28435393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2017.66653 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|